Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05129280 |
Title | A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GBR | ESP | DNK | BEL | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Peter Maccallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
Cliniques Universitaires St-Luc | Bruxelles | 1200 | Belgium | Details | ||
UZ Antwerpen | Edegem | 2650 | Belgium | Details | ||
UZ Gent | Gent | 9000 | Belgium | Details | ||
UZ Leuven Gasthuisberg | Leuven | 3000 | Belgium | Details | ||
Rigshospitalet; Fase 1 Enhed - Onkologi | København Ø | 2100 | Denmark | Details | ||
Vall d?Hebron Institute of Oncology (VHIO), Barcelona | Barcelona | 08035 | Spain | Details | ||
Hospital Universitario HM Sanchinarro-CIOCC | Madrid | 28050 | Spain | Details | ||
Royal Marsden Hospital - Institute of Cancer Research - Sutton | Sutton | SM2 5PT | United Kingdom | Details |